Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development
PAGE 41 1 P01 A143042-01 16 SEP Ho, David D. The facilities, both in terms or space and equipment, are outstanding and appropriate. The budget, as written, can termned. Human Subjects: code 10 Gender and Minority Representation: not applicable Animal Welfare: code 30 Budget: As resented, the proposed budget is incomplete, lacks details, and therefore cannot be evaluated. IRG Action: This project, ived a priority score in the very good range with a numerical value o249. Administrative Note: The proposed budget for Project 2 is incomplete and lack details. It is recommended that the applicants submit a complete and detailed budget. PROJECT 3: Priming With Recombinant Vaccinia or DNA Vaccines followed by Boosting Hith Pseudovirions or Envelope Proteins Critique: The comments below represent essentially unedited comments from the reviewers of this application. They are included to indicate the range of comments made during the discussion, and may not reflect the final thinking of the committee. The RESUME and OVERALL CRITIQUE sections above summarize the final opinion of the committee after the discussion. REVIEHER A: Project 3 of this application is designed to deal with the optimization of humoral and cellular immune responses to HIV/SIV protein components in experimental animal models through a series of "prime-boost" experiments. The proposed priming immunizations will employ new vectors capable of intracellular expression of viral antigens and will induce T cellmediated immune responses, including CTL. Boosts will be performed with new variants of soluble HIV/SIV proteins and will stimulate B cells to produce neutralizing antibodies. Specific aims include construction of new delivery vectors based on recombinant vaccine viruses/pseudovirions and new DNA-vaccine plasmids, limited testing of immunogens, adjuvants, and liposomes in vitro and in small animal model (guinea pigs) and monkeys (macaques), and testing of the most promising priming and boosting combinations in the expanded experimental series involving macaques. This project, to be jointly supervised and executed by ADARC staff under the direction of Dr. D. Ho, draws on the enormous body of systematic and anecdotal knowledge accumulated by these researchers and by their collaborators and/or competitors over the period of a decade. As pointed out by the Principal Investigator, the design of the proposed studies is iterative. The laboratory-based research program will be Continued
About this Item
- Title
- Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development
- Author
- Schultz, Alan M.
- Canvas
- Page 16
- Publication
- 1998-01-12
- Subject terms
- proposals
- Series/Folder Title
- Activism > Organizations > Aaron Diamond AIDS Research Center
- Item type:
- proposals
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0421.017
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0421.017/16
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0421.017
Cite this Item
- Full citation
-
"Summary Statement: ADARC Program Project on HIV/SIV Vaccine Development." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0421.017. University of Michigan Library Digital Collections. Accessed May 11, 2025.